Contribution: Industrial Research Assistance Program – Contributions to Firms
Nanostics Inc.
$413,000.00
Biomarker Validation of ClarityDX, a Blood Test to Predict Aggressive Prostate Cancer
FY 2018-19 · 2018-04-01
Summary
The Nanostics-IRAP project involves refinement and validation of the ClarityDx biomarker panel. ClarityDx is a novel liquid biopsy test that accurately predicts prostate cancer from just a few drops of blood.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
707942124
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 1 | 2018-04-01 | 2018-19 | $319,000.00 |
| 2 | 2018-04-01 | 2018-19 | $319,000.00 |
| 3 | 2018-04-01 | 2018-19 | $369,000.00 |
| 4 | 2018-04-01 | 2018-19 | $413,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 44,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 44 000 dollars.
Agreement End Date
2020-03-31
Agreement Number
903707
Agreement Start Date
2018-04-01
Agreement Title
Biomarker Validation of ClarityDX, a Blood Test to Predict Aggressive Prostate Cancer
Agreement Title (French)
Validation de biomarqueurs ClarityDX, une analyse de sang pour prédire le cancer de la prostate agressif
Agreement Type
Contribution
Agreement Value
$413,000.00
Amendment Date
2020-02-25
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The Nanostics-IRAP project involves refinement and validation of the ClarityDx biomarker panel. ClarityDx is a novel liquid biopsy test that accurately predicts prostate cancer from just a few drops of blood.
Description (French)
Le projet Nanostics-IRAP comprend l’amélioration et la validation du panneau biomarqueur ClarityDx. ClarityDx est un nouveau test de biopsie liquide, qui permet de prédire avec exactitude le cancer de la prostate en utilisant seulement quelques gouttes de sang.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Strathcona
Federal Riding (French)
Edmonton Strathcona
Federal Riding Number
48019
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
707942124
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
Nanostics Inc.
Recipient Postal Code
T6H 3E2
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2018-2019-Q3-903707
